ClinicalMetric / Countries / South Korea / prostate cancer
← 🇰🇷 South Korea Trials
🇰🇷 South Korea Country × Condition

prostate cancer Clinical Trials in South Korea

Active clinical trials for prostate cancer with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 2 // Recruiting: 2 Phases: Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea

Active Trials in South Korea (2)

NCT04625556
Recruiting

Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome

Enrollment
3,000 pts
Country
🇰🇷 South Korea
Yonsei University
View Trial →
NCT07247175 Phase 2
Recruiting

The Impact of Force Feedback in the dV5 Robotic Surgical System on Learning Curve and Safety in Robot-Assisted Radical Prostatectomy - A Prospective, Single-Center, Investigator-Initiated Clinical Trial

Enrollment
60 pts
Country
🇰🇷 South Korea
Seong Soo Jeon
View Trial →

Frequently Asked Questions

How many prostate cancer clinical trials are active in South Korea?
There are currently 2 active clinical trials for prostate cancer with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a prostate cancer clinical trial in South Korea?
To join a prostate cancer clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are prostate cancer trials in South Korea?
Active prostate cancer trials in South Korea span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All South Korea Trials → Global prostate cancer Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology